193 related articles for article (PubMed ID: 31383668)
1. Production of Norspermidine Contributes to Aminoglycoside Resistance in
Bolard A; Schniederjans M; Haüssler S; Triponney P; Valot B; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383668
[TBL] [Abstract][Full Text] [Related]
2. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
3. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
Muller C; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1211-21. PubMed ID: 21149619
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.
Poole K; Lau CH; Gilmour C; Hao Y; Lam JS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7276-89. PubMed ID: 26369970
[TBL] [Abstract][Full Text] [Related]
5. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
6. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
[TBL] [Abstract][Full Text] [Related]
7. Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress.
Johnson L; Mulcahy H; Kanevets U; Shi Y; Lewenza S
J Bacteriol; 2012 Feb; 194(4):813-26. PubMed ID: 22155771
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of pseudomonas aeruginosa.
Lau CH; Fraud S; Jones M; Peterson SN; Poole K
Antimicrob Agents Chemother; 2012 Oct; 56(10):5171-9. PubMed ID: 22825121
[TBL] [Abstract][Full Text] [Related]
9. Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa.
Wilton M; Charron-Mazenod L; Moore R; Lewenza S
Antimicrob Agents Chemother; 2016 Jan; 60(1):544-53. PubMed ID: 26552982
[TBL] [Abstract][Full Text] [Related]
10. Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2006 May; 50(5):1615-22. PubMed ID: 16641426
[TBL] [Abstract][Full Text] [Related]
11. Mutations in Gene
Bolard A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
[TBL] [Abstract][Full Text] [Related]
12. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
13. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.
Guénard S; Muller C; Monlezun L; Benas P; Broutin I; Jeannot K; Plésiat P
Antimicrob Agents Chemother; 2014; 58(1):221-8. PubMed ID: 24145539
[TBL] [Abstract][Full Text] [Related]
14. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
15. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
[TBL] [Abstract][Full Text] [Related]
16. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O
Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215
[TBL] [Abstract][Full Text] [Related]
17. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.
Ly NS; Yang J; Bulitta JB; Tsuji BT
Antimicrob Agents Chemother; 2012 Jun; 56(6):3453-6. PubMed ID: 22470116
[TBL] [Abstract][Full Text] [Related]
18. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
19. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Barrow K; Kwon DH
Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.
Chuanchuen R; Wannaprasat W; Schweizer HP
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
